Printer-friendly version
East County News Service
October 14, 2014 (San Diego)--A blood filtration treatment made by a San Diego company has now joined the fight against Ebola. Aethlon Medical announced Tuesday the first use its Hemopurifier therapy on a patient infected with Ebola virus, Times of San Diego reports.
The Hemopurifier is a bio-filtration device that can rapidly eliminate viruses and proteins from the circulatory system of infected individuals.
The treatment was administered at Frankfurt University Hospital in Germany to a Ugandan doctor, a World Health Organization worker who contracted Ebola in Sierra Leone.
The company is the second from San Diego to offer a treatment for Ebola amid the rapidly spreading epidemic. In August, Mapp Biopharmaceutical‘s drug ZMapp was used to treat the first American Ebola patients.
Jim Joyce, Aethlon’s founder and CEO, says that details on the patient’s response to therapy will be disclosed once hospital officials deem it appropriate to report an update on the patient’s condition.
The device can be used in dialysis machines at hospitals and clinics to purify blood and purge viruses from the system not only in Ebola, but other pandemic threats and chronic viral conditions such as HIV and Hepatitis C. Aethlon has indicated it will soon begin clinical studies in the U.S. on the treatment.
Recent comments